SPONSOR

Centre Hospitalier Universitaire de Nice

Total Trials

Recruiting

Phases

Phase 4, Phase 2, Phase 3

Conditions studied: Lymphedema Diabetic Keto-acidosis Radiologically Isolated Syndromes; Multiple Sclerosis Liver Cirrhosis Aphasia, Primary Progressive Persistent Atrial Fibrillation Vitiligo Neurofibromatosis 2 Dermatology/Skin - Other Virus-HIV

Centre Hospitalier Universitaire de Nice is a clinical research sponsor with 22 registered studies on ClinicalTrials.gov, of which 22 are actively recruiting participants. Research covers conditions including Lymphedema, Diabetic Keto-acidosis, Radiologically Isolated Syndromes; Multiple Sclerosis, Liver Cirrhosis.

The trial portfolio spans Phase 4, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Centre Hospitalier Universitaire de Nice

How many clinical trials has Centre Hospitalier Universitaire de Nice sponsored?

ClinicalMetric currently tracks 22 clinical trials sponsored by Centre Hospitalier Universitaire de Nice, of which 22 are actively recruiting participants. These trials cover conditions including Lymphedema, Diabetic Keto-acidosis, Radiologically Isolated Syndromes; Multiple Sclerosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Centre Hospitalier Universitaire de Nice research focus on?

Centre Hospitalier Universitaire de Nice clinical trials span Lymphedema, Diabetic Keto-acidosis, Radiologically Isolated Syndromes; Multiple Sclerosis, Liver Cirrhosis, Aphasia, Primary Progressive, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Centre Hospitalier Universitaire de Nice clinical trial?

To participate in a Centre Hospitalier Universitaire de Nice trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centre Hospitalier Universitaire de Nice trials with current recruitment status updated daily.

Centre Hospitalier Universitaire de Nice

Frequently Asked Questions — Centre Hospitalier Universitaire de Nice

Clinical Trials by Centre Hospitalier Universitaire de Nice

Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY

Fluid Administration in Ketoacidosis (DRINK)

Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination

Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications

Effects of Transcranial Direct Current Stimulation (tDCS) on Inhibition and Brain Function in Primary Progressive Aphasia

Evaluation of the Efficacy of Pulmonary Vein Isolation by Pulsed-field Ablation in Persistent Atrial Fibrillation: a Multicenter Study With Follow-up by Implantable Cardiac Monitor

Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo

Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15

Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75

Nalysis of the Periodontal Microbiota in Elderly Subjects With and Without Alzheimer's Disease: a Case Control Study

E-CANE: a National Program of Remote Health Education Workshops

Home Based Personalized Training and Video Consultation in Mitochondrial Myopathies: Study of Efficacy and Tolerance.

A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized

Purinergic Compounds in Pseudoxanthoma Elasticum

Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)

Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors

Review of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for Melanoma

Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis

Sedentary or Exercised : Neuromuscular and Immunometabolic Observations and Retrospection

Assessment of Chilbains Occuring During Covid-19 Infection

A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders

Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and Identification of Its Associated Factors.